{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T07:07:59Z","timestamp":1717225679729},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.antiviral.2008.01.157","type":"journal-article","created":{"date-parts":[[2008,3,24]],"date-time":"2008-03-24T13:56:50Z","timestamp":1206367010000},"page":"71-79","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of cationic lipid\u2013DNA complexes (CLDC) on hepatitis B virus in transgenic mice"],"prefix":"10.1016","volume":"79","author":[{"given":"John D.","family":"Morrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil E.","family":"Motter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Taro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla","family":"Lay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Fairman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2008.01.157_bib1","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1128\/JVI.71.4.3236-3243.1997","article-title":"Interleukin-12 inhibits hepatitis B virus replication in transgenic mice","volume":"71","author":"Cavanaugh","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib2","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1089\/10430349950016375","article-title":"Intravenous cytokine gene delivery by lipid\u2013DNA complexes controls the growth of established lung metastases","volume":"10","author":"Dow","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.antiviral.2008.01.157_bib3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.4049\/jimmunol.163.3.1552","article-title":"Lipid\u2013DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously","volume":"163","author":"Dow","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib4","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1089\/10430349950017266","article-title":"Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice","volume":"10","author":"Dow","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.antiviral.2008.01.157_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2005.12.002","article-title":"Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes","volume":"69","author":"Gowen","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2008.01.157_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1369-5274(99)80068-X","article-title":"Cytokine-induced viral purging\u2014role in viral pathogenesis","volume":"2","author":"Guidotti","year":"1999","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/JVI.68.3.1265-1270.1994","article-title":"Interleukin-2 and alpha\/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways","volume":"68","author":"Guidotti","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib8","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/JVI.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"5415","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.01.157_bib10","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.4049\/jimmunol.167.6.3324","article-title":"Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides","volume":"167","author":"Gursel","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib11","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib12","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/AAC.48.6.2199-2205.2004","article-title":"Phosphorothioate di- and tri-nucleotides as a novel class of anti-HBV agents","volume":"48","author":"Iyer","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.157_bib13","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/AAC.48.6.2318-2320.2004","article-title":"Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model","volume":"48","author":"Iyer","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.157_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-3542(01)00223-6","article-title":"Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus","volume":"55","author":"Julander","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2008.01.157_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0166-3542(03)00109-8","article-title":"Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus","volume":"59","author":"Julander","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2008.01.157_bib16","doi-asserted-by":"crossref","first-page":"10702","DOI":"10.1128\/JVI.76.21.10702-10707.2002","article-title":"Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice","volume":"76","author":"Kimura","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib17","first-page":"2955","article-title":"Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models","volume":"60","author":"Lanuti","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2008.01.157_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0166-3542(99)00009-1","article-title":"Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine","volume":"42","author":"Morrey","year":"1999","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2008.01.157_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1365-2893.2002.00383.x","article-title":"Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA","volume":"9","author":"Morrissey","year":"2002","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2008.01.157_bib20","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/JVI.75.6.2900-2911.2001","article-title":"Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice","volume":"75","author":"Raney","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/JVI.01779-06","article-title":"Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus","volume":"81","author":"Robek","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature06013","article-title":"DAI (DLM-1\/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response","volume":"448","author":"Takaoka","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.157_bib23","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/sj.gt.3301026","article-title":"LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth","volume":"6","author":"Whitmore","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2008.01.157_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s002620100227","article-title":"Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses","volume":"50","author":"Whitmore","year":"2001","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.antiviral.2008.01.157_bib25","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/JVI.74.9.4165-4173.2000","article-title":"Intrahepatic induction of alpha\/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice","volume":"74","author":"Wieland","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.157_bib26","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1073\/pnas.0504273102","article-title":"Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids","volume":"102","author":"Wieland","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T06:08:21Z","timestamp":1684303701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354208002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0166354208002052"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2008.01.157","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}